Cheaper Breast Cancer Drug Does Well in Clinical Trial

FRIDAY, June 3, 2016 -- For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin (trastuzumab), a new study finds. HER2-positive tumors contain certain...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news